ChristineMarieBestvinaMD

Oncology • Chicago, IL

Physician

Join to view full profile

Dr. Bestvina is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bestvina's full profile

Already have an account?

Office
5841 S. MARYLAND AVE.
M/C 2115
Chicago, IL 60637
Phone+1 773-702-4400

Fax+1 773-702-0963

Education & Training

Duke University HospitalResidency, Internal Medicine, 2012 - 2015
Perelman School of Medicine at the University of PennsylvaniaClass of 2012

Certifications & Licensure

IL State Medical License 2015 - 2026
NC State Medical License 2012 - 2015
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Clinical Trials

Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease Start of enrollment: 2019 Jun 27
Terminated
Phase 1
M7824 With cCRT in Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) Start of enrollment: 2019 Apr 16
Terminated
Phase 2
A Study of Tepotinib Plus Osimertinib in Osimertinib Relapsed MET Amplified NSCLC (INSIGHT 2) Start of enrollment: 2019 Sep 19
Active, not recruiting
Phase 2
A Study of Neoadjuvant Chemotherapy Plus Nivolumab Versus Neoadjuvant Chemotherapy Plus Placebo, Followed by Surgical Removal and Adjuvant Treatment With Nivolumab or Placebo for Participants With Surgically Removable Early Stage Non-small Cell Lung Cancer Start of enrollment: 2019 Nov 05
Active, not recruiting
Phase 3
Join now to see all

Publications & Presentations

PubMed

Impact of next-generation sequencing vs polymerase chain reaction testing on payer costs and clinical outcomes throughout the treatment journeys of patients with metas...
Christine M Bestvina, Dexter Waters, Laura Morrison, Bruno Emond, Marie-Hélène Lafeuille
Journal of Managed Care & Specialty Pharmacy. 2024-12-01
DARES: A Phase II Trial of Durvalumab and Ablative Radiation in Extensive-Stage Small Cell Lung Cancer.
Christine M Bestvina, Jared H L Hara, Theodore Karrison, Benjamen Bowar, Janet Chin
Clinical Lung Cancer. 2024-12-01
Epigenomic exploration of disease status of EGFR-mutated non-small cell lung cancer using plasma cell-free DNA hydroxymethylomes.
Yong Peng, Jason Karpus, Jyoti D Patel, Everett E Vokes, Marina Chiara Garassino
Cancer Communications. 2024-11-11

Press Mentions

ASCO Annual Meeting Returns to Chicago, Celebrates New Progress in CancerJune 15th, 2022
Combining Immune Checkpoint and VEGF Inhibitors Improves Survival in Pretreated NSCLCJune 4th, 2022
Oncogene-Specific Advocacy Groups Bring a Patient-Centric Perspective to Studies of Lung CancerNovember 18th, 2020
Join now to see all